Thyroid Hormone Receptor Β1 Suppresses Proliferation and Migration by Inhibiting PI3K/Akt Signaling in Human Colorectal Cancer Cells.

Lei Zhu,Guangang Tian,Qin Yang,Gejing De,Zhigang Zhang,Yahui Wang,Huizhen Nie,Yanli Zhang,Xiaomei Yang,Jun Li

DOI: https://doi.org/10.3892/or.2016.4931

2016-01-01

Oncology Reports

Abstract:Thyroid hormone receptor 1 (TR1) is a ligand-dependent transcription factor that belongs to the superfamily of nuclear receptors. TR1 has been found to act as a tumor suppressor in many solid tumors including breast cancer and hepatocellular carcinoma, but its role in the progression of human colorectal cancer (CRC) remains unclear. In this study, microarray data analysis revealed that TR1 mRNA was downregulated in CRC tumors compared with that in the normal counterparts in both The Cancer Genome Atlas (TCGA) and Gene Expression Omnibus (GEO) datasets. Using a CRC tissue microarray (TMA), we confirmed that the expression of TR1 was decreased in human CRC tumor tissues in contrast to normal colorectal mucosal tissues. Notably, the TR1 expression was strongly correlated with tumor size (p=0.045). Furthermore, we found that CRC cell proliferation and migration were significantly inhibited by TR1 overexpression in vitro. Mechanistic studies indicated that activated phosphorylated Akt was clearly suppressed by TR1 in the CRC tissues and cells. In conclusion, this study provides evidence that TR1 plays a critical role in the progression of CRC via the PI3K/Akt pathway, and the TR1 gene may represent a novel target for CRC therapeutics.